Efficacy and Safety of DKB-119 in Patients in Crow's Feet

Dongkook Pharmaceutical

Status: Active, not recruiting

Conditions: Crow's Feet

Treatments: Device: DKB-119

Study type: Interventional

Funder types: Industry

Identifiers

NCT06021418

DKB-119-MD-2

Details and patient eligibility

About

To prove the non-inferiority of DKB-119 by evaluating the injecting efficacy and safety DKB-119 and control for patients in crow's feet

Full description

A single center, randomized, subject and evaluator blinded, split-face, pivotal clinical trial

Enrollment: 100 patients

Sex: All

Ages: 19 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Those who are over 19 under 70 ages.
• Those who score 2 or more in the LCL severity evaluation.
• Those who have visually symmetrical crow's feet on both sides.
• Etc.

Exclusion criteria

• Pregnancy and lactating women.
• Etc.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

100 participants in 2 patient groups

DKB-119

Experimental group

Description:

Injecting to one side crow's feet

Treatment:

Device: DKB-119

Control

Active Comparator group

Description:

Injecting to one side crow's feet

Treatment:

Device: DKB-119